Aastrom Biosciences, Inc. reports on the results of Phase I/II clinical trials of the TRC [Tissue Repair Cells] product in patients with bone fractures
A. V. Volkov , A. V. Bersenev
Genes & Cells ›› 2006, Vol. 1 ›› Issue (2) : 28 -28.
Aastrom Biosciences, Inc. reports on the results of Phase I/II clinical trials of the TRC [Tissue Repair Cells] product in patients with bone fractures
| [1] |
Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities. 2005, MedMarket Diligense, LLC. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
